News item
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
ANDEXXA is no longer provisionally approved for use in Australia and has been removed from the Australian Register of Therapeutic Goods (ARTG).
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.